Literature DB >> 30556232

Immunoregulatory role of acid sphingomyelinase in allergic asthma.

Nina Sopel1, Julia Kölle1, Sonja Dumendiak1, Sonja Koch1, Martin Reichel2,3, Cosima Rhein3, Johannes Kornhuber3, Susetta Finotto1.   

Abstract

Acid sphingomyelinase (ASM) is one of the enzymes that catalyzes the breakdown of sphingomyelin to ceramide and phosphorylcholine. In this study, we aimed at elucidating the role of ASM in allergic asthma. We used an ovalbumin-induced murine model of asthma where we compared wild-type and ASM-deficient mice. In wild-type mice, secretory ASM activity in the bronchoalveolar lavage fluid was increased in the acute ovalbumin model, but not in a tolerogenic model. Furthermore, in the absence of ASM, the serum IgE level was reduced, compared with wild-type mice, while an accumulation of interstitial macrophages and foreign antigen-induced regulatory T cells along with exhausted CD4+ PD1+ T cells was observed in the lungs of ASM-/- mice. In conclusion, in the absence of ASM, we observed an accumulation of immunosuppressive antigen-induced regulatory T cells expressing Foxp3 and CTLA4 in the lung as well as multinucleated interstitial macrophages and exhausted CD4+ PD1+ T cells associated with inhibition of serum IgE in asthma.
© 2018 John Wiley & Sons Ltd.

Entities:  

Keywords:  acid sphingomyelinase; asthma; immunosuppression; macrophages; regulatory T cells

Mesh:

Substances:

Year:  2019        PMID: 30556232      PMCID: PMC6418424          DOI: 10.1111/imm.13035

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  26 in total

Review 1.  Regulation of death receptor signaling and apoptosis by ceramide.

Authors:  Erich Gulbins
Journal:  Pharmacol Res       Date:  2003-05       Impact factor: 7.658

2.  Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen.

Authors:  O Akbari; R H DeKruyff; D T Umetsu
Journal:  Nat Immunol       Date:  2001-08       Impact factor: 25.606

Review 3.  Secretory sphingomyelinase in health and disease.

Authors:  Johannes Kornhuber; Cosima Rhein; Christian P Müller; Christiane Mühle
Journal:  Biol Chem       Date:  2015-06       Impact factor: 3.915

4.  Activity of secretory sphingomyelinase is increased in plasma of alcohol-dependent patients.

Authors:  Martin Reichel; Johannes Beck; Christiane Mühle; Andrea Rotter; Stefan Bleich; Erich Gulbins; Johannes Kornhuber
Journal:  Alcohol Clin Exp Res       Date:  2011-05-19       Impact factor: 3.455

5.  Antidepressant drug, desipramine, alleviates allergic rhinitis by regulating Treg and Th17 cells.

Authors:  Y Zhang; H Zhen; W Yao; F Bian; X Mao; X Yang; S Jin
Journal:  Int J Immunopathol Pharmacol       Date:  2013 Jan-Mar       Impact factor: 3.219

6.  The activating protein 1 transcription factor basic leucine zipper transcription factor, ATF-like (BATF), regulates lymphocyte- and mast cell-driven immune responses in the setting of allergic asthma.

Authors:  Caroline Übel; Nina Sopel; Anna Graser; Kai Hildner; Cornelia Reinhardt; Theodor Zimmermann; Ralf Joachim Rieker; Anja Maier; Markus F Neurath; Kenneth M Murphy; Susetta Finotto
Journal:  J Allergy Clin Immunol       Date:  2013-11-28       Impact factor: 10.793

7.  IL-10-producing lung interstitial macrophages prevent neutrophilic asthma.

Authors:  Hideo Kawano; Hisako Kayama; Takekuni Nakama; Takashi Hashimoto; Eiji Umemoto; Kiyoshi Takeda
Journal:  Int Immunol       Date:  2016-03-14       Impact factor: 4.823

8.  Ceramide: a key signaling molecule in a Guinea pig model of allergic asthmatic response and airway inflammation.

Authors:  Emanuela Masini; Lucia Giannini; Silvia Nistri; Lorenzo Cinci; Rosanna Mastroianni; Wei Xu; Suzy A A Comhair; Dechun Li; Salvatore Cuzzocrea; George M Matuschak; Daniela Salvemini
Journal:  J Pharmacol Exp Ther       Date:  2007-11-27       Impact factor: 4.030

9.  The common acid sphingomyelinase polymorphism p.G508R is associated with self-reported allergy.

Authors:  Martin Reichel; Tanja Richter-Schmidinger; Christiane Mühle; Cosima Rhein; Panagiotis Alexopoulos; Sibylle G Schwab; Erich Gulbins; Johannes Kornhuber
Journal:  Cell Physiol Biochem       Date:  2014-06-16

Review 10.  The pathogenesis and treatment of acid sphingomyelinase-deficient Niemann-Pick disease.

Authors:  E H Schuchman
Journal:  J Inherit Metab Dis       Date:  2007-07-12       Impact factor: 4.982

View more
  4 in total

1.  Airway Resistance Caused by Sphingomyelin Synthase 2 Insufficiency in Response to Cigarette Smoke.

Authors:  Gayatri Gupta; Nathalie Baumlin; Justin Poon; Begum Ahmed; Yeun-Po Chiang; Christopher Railwah; Michael D Kim; Melissa Rivas; Hannah Goldenberg; Ziyad Elgamal; Matthias Salathe; Apurav A Panwala; Abdoulaye Dabo; Chongmin Huan; Robert Foronjy; Xian-Cheng Jiang; Raj Wadgaonkar; Patrick Geraghty
Journal:  Am J Respir Cell Mol Biol       Date:  2020-03       Impact factor: 6.914

2.  Activation of Sphingomyelinase-Ceramide-Pathway in COVID-19 Purposes Its Inhibition for Therapeutic Strategies.

Authors:  Murad Abusukhun; Martin S Winkler; Stefan Pöhlmann; Onnen Moerer; Konrad Meissner; Björn Tampe; Heike Hofmann-Winkler; Michael Bauer; Markus H Gräler; Ralf A Claus
Journal:  Front Immunol       Date:  2021-12-20       Impact factor: 7.561

3.  Evidence of immunometabolic dysregulation and airway dysbiosis in athletes susceptible to respiratory illness.

Authors:  Leah Cuthbertson; Scarlett E G Turner; Anna Jackson; Craig Ranson; Mike Loosemore; Peter Kelleher; Miriam F Moffatt; William O C Cookson; James H Hull; Anand Shah
Journal:  EBioMedicine       Date:  2022-04-29       Impact factor: 11.205

4.  Aging-dependent mitochondrial dysfunction mediated by ceramide signaling inhibits antitumor T cell response.

Authors:  Silvia Vaena; Paramita Chakraborty; Han Gyul Lee; Alhaji H Janneh; Mohamed Faisal Kassir; Gyda Beeson; Zachariah Hedley; Ahmet Yalcinkaya; M Hanief Sofi; Hong Li; Monica L Husby; Robert V Stahelin; Xue-Zhong Yu; Shikhar Mehrotra; Besim Ogretmen
Journal:  Cell Rep       Date:  2021-05-04       Impact factor: 9.995

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.